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Abstract 
The paper presents clinical diagnostic approaches and therapeutic effects of a specific protocol for the treatment of dogs 
with cardiovascular dirofilariasis in the Belgrade City (Serbia) territory. The study involved 50 privately owned dogs of different 
breeds, gender, and age, all showing signs of cardio – respiratory disorders. In addition to a general physical examination, blood 
tests were done to detect microfilaria and adult forms, and X-ray, ECG, and echocardiography were performed as well. At the 
first examination, 34 out of 50 examined dogs were positive for microfilaria and adult forms. Because of a lack of drug used as 
„the golden standard“ in dirofilariasis treatment, it involved a combination of doxycycline (10 mg/kg) and ivermectin (6 µg/kg) 
supported with Advocate – Bayer spot-on. After six months, the first control was performed while continuing treatment with the 
aforesaid protocol, and the second control was performed after 12 months. Of the 34 treated dogs, all were negative for 
microfilaria, as early as after the first six months of the treatment (100%). One dog was positive for adult forms of the parasite 
after six and 12 months. In echocardiography and X-ray examination after 12 months, six dogs showed evident chronic changes. 
At controls conducted at sixth month and at one year, the implemented therapy was successful in 97.05% (33/34) of primarily 
infected dogs. 
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Introduction 
The cause of cardiovascular dirofilariasis in dogs 
is the nematode Dirofilaria immitis which leads to  
a significant functional damage of the canine heart and 
therefore has a higher pathological significance  
than other types of filariae (D. repens and 
Acanthocheilonema, syn. Dipetalonema reconditum). 
D. repens can also cause infections in humans, so it is 
important to diagnose accurately the type of the genus 
Dirofilaria (7, 19, 24). Cardiovascular dirofilariasis 
leads to clinical signs of "right heart insufficiency" with 
haemoglobinuria and possible cardio respiratory collapse 
(11, 25). Symptoms develop gradually, starting with 
chronic cough, which leads to a moderate or severe 
dyspnea and general weakness. Different lung sounds 
can be heard in the caudal lobes, while heart 
auscultation can reveal a split second heart tone. Later 
on, congestive heart failure results in the formation of 
ascites and oedema of the extremities. At this stage 
anorexia, weight loss, and dehydration develop. On the 
right side of the chest, heart murmurs can be heard as 
the result of tricuspid valvular insufficiency and cardiac 
arrhythmia, which is the most common consequence of 
atrial fibrillation. Death is mainly due to cachexia or 
respiratory distress after thromboembolism (10). 
Laboratory diagnosis of dirofilariasis involves the 
detection and identification of microfilaria in the 
peripheral blood (8, 27), performance of immunological 
tests (13, 20, 23), and molecular diagnostic methods (5, 
9, 26). If dogs manifest symptoms and the results of 
blood tests are negative, then radiography of the thorax 
should be performed (15). When clinical and 
radiological signs indicate a high intensity infection, 
then echocardiography is the procedure of choice (4). 
In the final stages of heart disease, echocardiography 
and electrocardiography may indicate the degree of 
myocardial damage (15). Based on these results, an 
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insight into the degree of pathological changes is 
attained and symptomatic therapy can be applied in 
order to improve the cardiopulmonary circulation and 
lung aeration (4, 15). In the treatment of this very 
extensive infection in privately owned dogs, we opted 
for the "soft kill" approach, according to modified 
protocols by Mc Call et al. (16) and Bazzochi et al. (4), 
published by Grandi et al. (10), which provides  
a smaller chance for thromboembolic insults compared 
to other protocols (4, 15, 16). In this study we have 
shown the effects of treatment of dogs with diagnosed 
cardiovascular dirofilariasis during a two-year period 
(2012–2013). The aim of the present study was to 
evaluate efficacy of the modified therapeutic protocol 
reported by Grandi et al. (10) in 2010, (involving  
a combination of ivermectin and doxycycline, modified 
with combination of imidoclopride and moxidectin) on 
the varieties D. immitis found on the territory of 
republic of Serbia (26). We decided to use this 
combination due to a lack of drug available in our 
country, despite the guidelines given by the American 
Heartworm Society (1). Detection of microfilaria in the 
peripheral blood of the tested dogs was performed after 
concentration of the blood samples by the modified 
Knott's test. Determination of D. immitis was based on 
morphological characteristics. The test sensitivity was 
low (about 60%), which means that diagnosis can be 
established in a little more than half of infected patients 
(14). In 30% of the dogs circulating microfilariae 
cannot be found (due to the host immune response to 
microfilariae, and as a result of the administration of 
drugs or microfilaricidal treatment the number is too 
small to be detected). A negative test result for the 
detection of microfilariae in the peripheral blood of the 
animal does not exclude infection (25). Therefore, the 
lately used PCR method is highly sensitive (mf 4/mL) 
and specific for D. immitis and D. repens (18). The 
antigen tests for D. immitis as quick "one-step ELISA" 
are highly specific (100%) and there is no possibility of 
cross-reactions with other antigens of the parasite  
(D. repens, species of the genus Dipetalonema). The 
test detects the adult forms of the parasite, based on 
antigens produced only by females (antigens of the 
uterus), and provides information on the intensity of 
infection (3). From the clinical standpoint, it is 
important that the results of laboratory diagnosis of  
D. immitis can be obtained only six months after the 
cessation of the first season of mosquitoes. Therefore,  
a routine control of clinically healthy dogs is done in 
April, i.e. six months after the cessation of the 
mosquito season in north hemisphere. Imaging is 
primarily useful in the clinical assessment of the 
damage to the lung tissue, but it cannot assess the 
intensity of the parasitic infection (28). Changes in the 
electrical activity of the heart muscle during ECG 
recordings are manifested as alterations to the right of 
the electrical axis of the heart, as well as in the 
occurrence of atrial fibrillations, which appear in the 
final stages of the disease (6). Echocardiographic 
imaging offers direct images of the heart cavities and 
associated blood vessels, visualisation of parasites in 
the right ventricle and atrium of the heart, the v. cava 
caudalis, the main pulmonary artery and both 
pulmonary arteries. The parasite is visualised as  
a double line parallel shadow floating in the right 
ventricle of the heart or in the lumen of blood vessels 
(29). Ultrasound of the heart is required to specify the 
degree of infection by adult parasites and clearly define 
the cardiac effects of pulmonary hypertension, which 
directly affects the choice of treatment and determines 
the prognosis. Following successful treatment, there is 
a massive destruction of a large number of parasites, 
which results in pulmonary thromboembolism.  
A moderate degree of the latter can go clinically 
unapparent, although more often a respiratory distress 
syndrome is manifested, which in some cases can be 
life-threatening to the infected dog.  
The aim of the studies was to evaluate clinical 
diagnostic approaches and therapeutic effects of  
a specific protocol for the treatment of dogs with 
cardiovascular dirofilariasis in the Belgrade City 
(Serbia) territory. 
Material and Methods  
The study was conducted on 50 dogs from the 
Belgrade area that showed cardio – respiratory 
disorders. All examined dogs were of a known origin 
and spent at least several hours outdoors on a daily 
basis. The surveyed dogs were of different breeds, age 
groups (from 1 to 15 years), and genders. All dogs were 
submitted to general clinical and parasitological 
examination, X-ray, ECG, and echocardiography. 
Blood was sampled directly from the v. cephalica 
antebrachii. The blood samples were analysed with  
a diagnostic technique for the detection and 
determination of microfilaria (modified Knott's test) 
and were screened for antigen-binding forms of adult 
D. immitis. Serological testing for circulating  
D. immitis antigen was performed with the commercial 
kits for the detection of adult forms (Vetall CHW Ag 
test kit, Witness® Dirofilaria Symbiotic Europe, 
France) according to the manufacturer's specifications. 
Chest X-ray diagnosis was conducted on the basis of 
recordings made in left lateral (LL) and dorsoventral 
(DV) projections. Electrocardiographic examination 
was performed on a 12-lead ECG "Cardiax" apparatus. 
Echocardiography of the patients was used for the 
purpose of assessing the degree of infection and blood 
flow in the pulmonary artery and right ventricle lumen. 
Once the diagnosis of the disease was determined, 
treatment was started in all dogs for 12 months and 
involved the application of a combination of 
doxycycline at a dose of 10 mg/kg (Doxycycline tabs. 
100 mg) and ivermectin at a dose of 6 µg/kg 
(Promectin salt. inves 1%, Spain). Drugs were 
administered according to the modified protocol 
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published by Grandi et al. (10). In addition, the 
Advocate - Bayer "spot-on" formulation was regularly 
applied as a preventative for the cohabitant healthy 
dogs. The protocol also included strict rest for the 
animals during the treatment, as in the above-
mentioned protocols. All dogs were treated on the first 
day with a "spot-on" formulation-Advocate, Bayer, and 
thereon on a regular basis during all 12 months. At the 
beginning of the treatment, prednisolone was 
administered in a therapeutic concentration (2 mg/kg) 
on the 1st, 3rd, 5th, and 9th day, in order to prevent the 
development of vasculitis and allergic reactions after 
necrosis of microfilariae due to the first application of 
ivermectin. The treatment started with administration 
of doxycycline for the first 30 d (1 × 10 mg/kg) in 
order to eliminate endo-symbiotic Wolbachia bacteria. 
The filaricidic part of the treatment consisted of 
Promectin given once every 15 d in a dose of 6 µg/kg 
for one year.  
After the first six months the dogs were examined 
for the presence of the adult forms of Dirofilaria 
immitis, and the check-up was repeated once again six 
months later. If both controls were negative, it was 
assumed that the animal was cured. The treatment was 
well-tolerated by all dogs. An improvement of 
tolerance to physical activity was observed as early as 
three weeks from the beginning of the treatment 
(cheerful behaviour, awareness, alertness, improved 
appetite, and better general condition).  
Results 
The analysis involved all the data relating to the 
presence of adult D. immitis antigens at the time of 
examination (CHW 0), after six months (CHW 6), and 
after one year (CHW 12), as well as the data on the 
presence of microfilaria in the blood (MF 0), after six 
months (MF 6), and after one year (MF 12). 
Characteristic changes were marked on radiographs 
and echocardiographs at the first examination (Ro 0 
and Echo 0) and at the end of the treatment, i.e. after 
one year (Ro 12 and Echo 12). Using a modified 
Knott's test at the first blood analysis (MF 0), 
microfilariae were found in the peripheral blood in 
68.0% (50/34) of dogs with cardio-respiratory 
disorders. From this moment, we operated with 34 
dogs with confirmed D. immitis infection. Two other 
control examinations (MF 6 and MF 12) revealed that 
none of the dogs had microfilariae in the blood. 
During the first antigen testing (CHW 0), 47.05% of 
dogs were negative (16/34). After six months (CHW 
6), 20.58% of dogs were still positive (7/34). After 12 
months of treatment (CHW 12), one dog was still 
positive to adult D. immitis antigens. Radiography of 
the thorax taken at the beginning of the treatment  
(Ro 0) revealed inflammatory lesions of the vascular 
tree and perivascular pulmonary parenchyma in 
35.29% of dogs (12/34). The findings included 
enlargement of the pulmonary artery, pulmonary 
uneven shadows, and right cardiomegaly. Pulmonary 
oedema was detected in 14.70% of dogs (5/34). In 
control echocardiograms and roentgenograms  
(LL projection) taken 12 months after the start of the 
treatment (Ro 12), only six dogs showed chronic 
alterations (17.64%). In other dogs, a significant 
improvement or complete absence of clinical 
symptoms was observed. Radiographic signs of 
altered lungs shadow in these dogs were visible 
mainly in the diaphragmatic lobes as irregular and 
uneven chronic inflammatory lesions of the vascular 
tree and perivascular lung parenchyma. A total of 
11.76% (4/34) dogs died before the scheduled annual 
veterinary check-up. Death was not caused by the 
treatment or the presence of adult forms of D. immitis. 
Necropsies confirmed other causes (tumours of 
parenchymal organs or surgery). 
 
a 
 
 
b 
 
Figs 1a and 1b. LL and DV views of the lungs of a female American 
Staffordshire terrier, 5-year-old, with radiological changes 
characteristic of dirofilariasis (Ro 0) 
 
Echocardiographic changes on the right side of the 
heart and pulmonary arteries, which are characteristic 
of dirofilariasis, were evident during the first 
examination (Echo 0) in 29.41% of dogs (10/34). After 
a year (Echo 12), the changes were recorded in 17.64% 
of dogs (6/34).  
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Fig. 2. Echocardiogram of a dog with strong hydro pericardium and 
clearly visible adult forms of Dirofilaria in the lumen of the right 
ventricle and pulmonary artery - Caval syndrome (Echo 0) 
 
The examined electrocardiograms mainly revealed 
physiological values, while a small number of patients 
showed sinus rhythm tachycardia. A shift of the 
electrical axis to the right was observed in 41.17% of 
dogs (14/34). Of 10 dogs which had irregularities on 
the first echo examination, four expressed AV-block II 
degree, which constituted 71.42% of the total number 
of dogs with ECG changes detected, and two dogs had 
atrial fibrillations, which was 35.71% of the total 
number of dogs in which ECG changes were observed.  
Discussion 
Because of poor availability of specific drug in our 
country, we decided to implement a different treatment 
protocol from the one recommended by the American 
Heartworm Society (AHS) Guidelines (1). The only 
drug currently registered for adulticide therapy against 
canine heartworm is the arsenic derivative melarsomine 
dihydrochloride (Immiticide, Merial), but the treatment 
is often followed by severe pulmonary thrombosis 
following the death of the entire worm population in  
a short period (12). It only affects adult Dirofilaria and 
its L5 developmental stage. It is a common opinion that 
this product should not be used in dogs that have 
already expressed the caval syndrome due to a high risk 
of embolisation (17). Destruction of the end symbiotic 
bacteria (Wolbachia) with antibiotic treatment 
(doxycycline, 10 mg/kg, twice a day for four weeks) is 
of great importance for a successful treatment (10, 21). 
Better results have been obtained with a combination of 
doxycycline and ivermectin (15, 26), but the true 
mechanism of synergism is still unknown. It is believed 
that doxycycline destroys the end symbiotic bacteria 
(AHS 2014) and ivermectin causes somatic 
degeneration of the parasite (10). The AHS (2012, 
2014) recommends a year-round administration of 
chemoprophylactic drugs to prevent heartworm disease. 
Before the start of the preventive treatment, it is 
compulsory to check whether the animal is infected 
with the adult forms of the parasite. For this reason it is 
of utmost importance to test yearly all dogs in the 
district regions for the presence of microfilaria (2). The 
obtained results are part of a clinical study aiming to 
show the importance of various diagnostic procedures 
in the evaluation of the degree of Dirofilaria infection 
in dogs, as well as to present one of the therapeutic 
protocols used to treat cardiovascular dirofilariasis 
(22). In endemic areas such as the territory of Belgrade 
(18), during clinical anamnesis, supported with the 
necessary epizootic information, a reasonable suspicion 
of cardiovascular dirofilariasis may be put forward. We 
tried to modify the previous treatment protocols in 
order to evaluate whether bi-weekly ivemerctin 
intervals in combination with doxycycline and 
Advocate could lead to elimination of the parasite in 
naturally infected dogs with lower occurrence of 
thromboembolism. According to our investigation, the 
microfilaricidal effect was shown in 100% of dogs on 
six-month check-up. It is in coherence with the results 
reported by Venco et al. (29). The continuous 
administration of ivemerctin was also found to be 
efficacious against adult parasites, as was demonstrated 
by Grandi et al. (10). In our study, adulticide effect was 
observed after six months in 20.58% of dogs (7/34), 
and after 12 months it was found in 97.05% of dogs 
(33/34). The continuous administration of ivemerctin in 
our study was also discovered to be efficacious against 
all stages of the parasites, as it was shown by Venco  
et al. (29), and McCall et al. (17), who treated 
experimentally infected dogs. This protocol has 
demonstrated a significant effect of a combination of 
doxycycline and ivermectin with imidoclopride and 
moxidectin (Advocate, Bayer), against all stages of the 
parasites, including mature worms, in naturally infected 
dogs. Necropsy of four dogs, which died before the 
scheduled annual veterinary check-up, (but after six 
months of treatment) showed that this treatment 
regimen resulted in 100% adulticide effect on the worm 
population. One dog which remained positive after  
a year’s treatment was a 5-year-old female Bernese 
mountain dog. We recommend this protocol in 
moderate to mild infections. In persistent cases when 
dogs have adult parasites after 12 months of therapy, 
arsenic derivates were unavoidable. We also 
recommend for all dog-owners from the tested area to 
twice a year subject their dogs to serological tests for 
the presence of the filarias (Dirofilaria spp. and 
Dipetalonema reconditum), with a view to protect the 
health of people and animals. Furthermore, we 
recommend to treat healthy dogs from this area with 
combination of imidoclopride and moxidectin 
(Advocate, Bayer) once a month in the mosquito 
season.  
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